Foreword to the Series. Preface. I: Proliferation, Differentiation and Malignant Progression. 1. Morphological and biological observations relating to the development and progression of breast cancer; T.J. Anderson, W.R. Miller. 2. Growth, differentiation, and transformation of human mammary epithelial cells in culture; M.R. Stampfer, P. Yaswen. II: Genetic Basis for Cancer Onset and Progression. 1. Genetic analysis of breast and ovarian cancer in families; M.-C. King, S. Rowell. 2. The P53 tumor suppressor gene in human breast cancer; D.C. Allred, R. Elledge, G.M. Clarke, S.A.W. Fuqua. 3. Tumor suppressor genes in breast cancer progression; H.S. Smith. 4. Estrogen receptor variants in breast cancer; C.A. Encarnacion, S.A.W. Fuqua. 5. Hormone `resistance' in breast cancer: the role of normal and mutant steroid receptors; K.B. Horwitz. III: Growth Factors, Receptors and Polyamines. 1. The epidermal growth factor family in the mammary gland and other target organs for ovarian steroids; R.P. DiAugustine. 2. Molecular and clinical aspects of the neu/erbB2 receptor tyrosine kinase; I. Stancovski, M. Sela, Y. Yardin. 3. MDGF1: a multifunctional growth factor in human milk and human breast cancer; M. Bano, W.R. Kidwell, R.B. Dickson. 4. The role of polyamines in the hormonal control of breast cancer proliferation; A. Manni. IV: Cancer Cell Adhesion, Migration, and Proteolysis. 1. Modulation of the epithelial phenotype during embryogenesis and cancer progression; P. Savagner, B. Boyer, A.M. Valles, J. Jouanneau, J.-P. Thierry. 2. Cell-cell adhesion in invasion and metastases of carcinomas; J. Behrens, W. Birchmeier. 3. Enhancement of tumor growth by basement membrane: modulation of growth and angiogenesis by laminin-derived synthetic peptides; M.C. Kibbey, K. Yamamura, Soo Han Jun, D.S. Grant, H.K. Kleinman. 4. Fetal-like fibroblasts: their production of migration stimulating factor and role in tumor progression; S.L. Schor, A.M. Grey, I. Ellis, A.M. Schor, A. Howell, P. Sloan, R. Murphy. 5. Urokinase plasminogen activator (UPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer; N. Brunner, C. Pyke, C. Holst Hansen, J. Romer, J. Grondahl-Hansen, K. Dano. V: Rodent Model Systems of Breast Cancer. 1. Molecular mechanisms of chemical carcinogenesis in rodent models; K. McKenzie, S. Sukumar. 2. Fgf-3, an oncogene in murine breast cancer; C. Dickson, V. Fantl. Index.